These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Review of a new gastrointestinal drug--metoclopramide. Ponte CD; Nappi JM Am J Hosp Pharm; 1981 Jun; 38(6):829-33. PubMed ID: 7018232 [TBL] [Abstract][Full Text] [Related]
8. [Metoclopramide. Effects and clinical value]. Neeb S; Grabner W Dtsch Med Wochenschr; 1978 Oct; 103(40):1572-5. PubMed ID: 359291 [No Abstract] [Full Text] [Related]
9. Review of the current status of prokinetic agents in gastroenterology. McCallum RW Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997 [No Abstract] [Full Text] [Related]
10. [Practical aspects of the peripheral dopaminolytic effect of metoclopramide]. Misterek K; Rewerski W Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1727-30. PubMed ID: 6395122 [No Abstract] [Full Text] [Related]
12. [Indications for primperan in pediatrics]. Coignet J Ann Gastroenterol Hepatol (Paris); 1985 May; 21(2 Pt 2):31-3. PubMed ID: 3898991 [TBL] [Abstract][Full Text] [Related]
13. Drug therapy. Metoclopramide. Schulze-Delrieu K N Engl J Med; 1981 Jul; 305(1):28-33. PubMed ID: 7015140 [No Abstract] [Full Text] [Related]
14. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Wiseman LR; Faulds D Drugs; 1994 Jan; 47(1):116-52. PubMed ID: 7510617 [TBL] [Abstract][Full Text] [Related]
15. [Metoclopramide (Cerucal) side-effects in the form of extrapyramidal disorders in combination with an other antidepressive agent]. Ficker F; Felber W Psychiatr Neurol Med Psychol (Leipz); 1977 May; 29(5):304-6. PubMed ID: 882611 [TBL] [Abstract][Full Text] [Related]
16. Domperidone: a peripherally acting dopamine2-receptor antagonist. Barone JA Ann Pharmacother; 1999 Apr; 33(4):429-40. PubMed ID: 10332535 [TBL] [Abstract][Full Text] [Related]
18. A randomised controlled feasibility and proof-of-concept trial in delayed gastric emptying when metoclopramide fails: We should revisit nasointestinal feeding versus dual prokinetic treatment: Achieving goal nutrition in critical illness and delayed gastric emptying: Trial of nasointestinal feeding versus nasogastric feeding plus prokinetics. Taylor SJ; Allan K; McWilliam H; Manara A; Brown J; Greenwood R; Toher D Clin Nutr ESPEN; 2016 Aug; 14():1-8. PubMed ID: 28531392 [TBL] [Abstract][Full Text] [Related]
20. [Comparative study on the effect of the dopamine receptor blockers metoclopramide and domperidone on stomach emptying and the visualization of the small intestine in monocontrast]. Stellamor K; Hruby W Wien Klin Wochenschr; 1983 Sep; 95(18):649-52. PubMed ID: 6649651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]